Orion invests EUR 17 million in its production plants in Turku
ORION CORPORATION PRESS RELEASE 10 NOVEMBER 2020 at 8.30 a.m. EET Orion…
Year: 2020
Immunophotonics Announces First Patient Treated in Clinical Study Evaluating IP-001 in Patients with Advanced Solid Tumors
ST. LOUIS and BERN, Switzerland, Nov. 10, 2020 (GLOBE NEWSWIRE) — Immunophotonics, Inc. announces the…
Altimmune Adds Lonza as a Manufacturing Partner for Supply of AdCOVID™ its Single-Dose Intranasal Vaccine Candidate for COVID-19
AdCOVID, a Single-dose Intranasal Vaccine for COVID-19 is Designed to Generate a Broad Immune Response…
Santhera to Present at Jefferies Virtual London Healthcare Conference
Pratteln, Switzerland, November 11, 2020 – Santhera Pharmaceuticals (SIX: SANN) announces that Dario Eklund, Chief Executive Officer,…
Bone Therapeutics and its collaborators Cerhum, 3D-Side, mSKIL and IREC awarded €3 million in funding under the framework of BioWin, the health cluster of Wallonia, to develop personalized, tissue engineered bone implants
Gosselies, Belgium, 10 November 2020, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE),…
Praxis Precision Medicines Provides Regulatory Update On PRAX-114 Program
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a…
Indus Holdings, Inc. Announces New Chief Financial Officer
Board Member Brian Shure will join executive team as Chief Financial OfficerSteve Neil will remain…
Supernus Provides Regulatory Updates for SPN-812 and SPN-830
ROCKVILLE, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical…
Indus Holdings, Inc. Reports Record Third Quarter 2020 Results
Company delivers strong results despite being adversely affected by California Wildfires Vertically-integrated California cannabis leader…
Catalyst Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update
– Firdapse® Third Quarter Net Revenues of $29.2 Million – Company Ends Third Quarter with…
MacroGenics to Participate in Upcoming Investor Conferences
ROCKVILLE, MD, Nov. 09, 2020 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical…
Adamis Pharmaceuticals Announces Third Quarter 2020 Financial Results and Business Update
SAN DIEGO, Nov. 09, 2020 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced…
Surface Oncology to Present at the Cowen IO Next Summit
CAMBRIDGE, Mass, Nov. 09, 2020 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology…
Fortress Biotech Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights
Product revenue for the first nine months of 2020 increased 29% year-over-year to $30.8 million…
TG Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results
NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX) today announced…
Tonix Pharmaceuticals to Present at 3rd Annual Neuropsychiatric Drug Development Summit
CHATHAM, N.J., Nov. 09, 2020 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix…
Immutep’s Phase II TACTI-002 Study Reports Encouraging Data at SITC
Sydney, Australia, Nov. 10, 2020 (GLOBE NEWSWIRE) — ASX/Media Release Overall Response Rates (ORR)…
PDS Biotech Initiates VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA® in Recurrent/Metastatic Head and Neck Cancer in Collaboration with Merck
VERSATILE-002 Trial for First Line Treatment of Recurrent/Metastatic Head and Neck Cancer with Combination PDS0101-KEYTRUDA®…
Tricida Announces Third Quarter 2020 Financial Results
SOUTH SAN FRANCISCO, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) — Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical…
Marrone Bio Innovations, Inc. Reports Third-Quarter 2020 Financial Results
Expansion in international and seed treatment markets led revenue growth and gross margin improvement DAVIS,…